Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | Roots Analysis
The Targeted Drug Delivery Device Market size is estimated to be worth USD 427 million in 2026 and is expected to reach USD 2,153 million by 2035, growing at a CAGR of 19.7% during the forecast period, till 2035.
The pharmaceutical industry is increasingly moving towards biologics from traditional small molecule drugs. This is primarily because of the specificity and efficacy of biologics that makes them proficient in treating complex diseases. Since, it has become increasingly popular because it offers many benefits still biologics poses various challenges, such as drug delivery-related complications along with immunogenicity.
To overcome these challenges, the pharmaceutical industry is focusing on the development of targeted drug delivery devices that will improve the therapeutic safety index and enhance the delivery of therapies to the targeted site. Targeted drug delivery device enables the administration of drugs to specific areas, thereby enhancing efficacy and reducing systemic toxicity. Site-specific drug delivery needs are one of the factors that push forward newer innovative drug delivery technologies and devices.
Considering that biologics pose an inherent delivery challenge, there is a ongoing need for targeted drug delivery devices. Therefore, the companies are actively engaged in manufacturing targeted drug delivery devices that can optimize drug efficacy and safety.
Key Report Takeaways:
§ Presently, over 30 companies are engaged in manufacturing targeted drug delivery devices across the globe.
§ Over 50% of the players engaged in this domain are based in North America followed by 35% in Europe.
§ Currently, 286 clinical trials are ongoing that are focused on targeted drug delivery devices for stem cell therapies and gene therapies.
§ Targeted drug delivery devices delivering drugs directly to the breast capture 73% of the overall targeted drug delivery device market.
§ The global market is anticipated to grow at a CAGR of 19.7%
Competitive Landscape:
The targeted drug delivery device market landscape features 37 very large, large, mid-sized and small players which are engaged in manufacturing of targeted dug delivery devices. It is worth highlighting that over 30% of the players were established post-2000.
Regional Outlook
Based on the key geographical regions, the market can be segmented into North America, Europe, Asia- Pacific and Middle East and North Africa. Majority of the players are headquartered in North America and Europe. Currently, North America captures over 50% of the market share of the global market and this trend is unlikely to change in the future.
Market Players
The targeted drug delivery device market report also includes detailed profiles of key players (listed below) that are engaged in the manufacturing of these devices:
§ Alcyone Lifesciences
§ Algorae Pharmaceuticals
§ BioCradia
§ ClearPoint Neuro
§ Gloriana Therapeutics
§ Mercator MedSystems
§ Neurotech Pharmaceuticals
§ Novartis
§ OncoSec
§ PharmaCyte Biotech
§ PulseSight Therapeutics
§ Renishaw
§ Silexion Therapeutics
§ SmartCella
To get market data, market insights, financial statements and a comprehensive analysis of the Global Market, please contact mailto:sales@rootsanalysis.com
Market Segments
Based on research, Roots Analysis has segmented the Targeted Drug Delivery Device Market into Type of Device, Target Organ, Type of Therapy Delivered, Route of Administration, Therapeutic Area and Key Geographical Regions.
by Type of Device
§ Catheters
§ Cannulas
§ Others
by Target Organ
§ Brain
§ Breast
§ Eyes
§ Heart
by Type of Type Therapy Delivered
§ Cell Therapies
§ Gene Therapies
§ Immunotherapies
by Route of Administration
§ Intratumoral
§ Transendocardial
§ Others
by Therapeutic Area
§ Cardiovascular Disorders
§ Oncological Disorders
§ Ophthalmic Disorders
§ Neurological Disorders
by Key Geographical Region
§ North America
§ Europe
§ Asia-Pacific
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
